Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of activation of Janus kinase activity (GO:0010533) | 4.49814682 |
2 | surfactant homeostasis (GO:0043129) | 4.07254982 |
3 | regulation of memory T cell differentiation (GO:0043380) | 3.98571124 |
4 | tolerance induction (GO:0002507) | 3.89548776 |
5 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.82449940 |
6 | response to muramyl dipeptide (GO:0032495) | 3.66907751 |
7 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.58428266 |
8 | T-helper cell differentiation (GO:0042093) | 3.58428266 |
9 | germinal center formation (GO:0002467) | 3.51142349 |
10 | growth hormone receptor signaling pathway (GO:0060396) | 3.44739374 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.41593837 |
12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.36439191 |
13 | negative thymic T cell selection (GO:0045060) | 3.31530770 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30940891 |
15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26108665 |
16 | interferon-gamma production (GO:0032609) | 3.24158962 |
17 | negative T cell selection (GO:0043383) | 3.21398261 |
18 | endothelial cell chemotaxis (GO:0035767) | 3.19838373 |
19 | regulation of cholesterol homeostasis (GO:2000188) | 3.19491534 |
20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19279281 |
21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.19279281 |
22 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.18228104 |
23 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.18228104 |
24 | T cell differentiation involved in immune response (GO:0002292) | 3.18228104 |
25 | positive regulation of p38MAPK cascade (GO:1900745) | 3.17629925 |
26 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.17139959 |
27 | NIK/NF-kappaB signaling (GO:0038061) | 3.12779475 |
28 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.09911186 |
29 | myeloid dendritic cell differentiation (GO:0043011) | 3.08004035 |
30 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07347339 |
31 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.06918250 |
32 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.06253970 |
33 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.05762456 |
34 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.05080365 |
35 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.04469312 |
36 | chemical homeostasis within a tissue (GO:0048875) | 3.02017871 |
37 | activation of MAPKKK activity (GO:0000185) | 2.99649679 |
38 | skin morphogenesis (GO:0043589) | 2.97478325 |
39 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96100504 |
40 | positive regulation of heat generation (GO:0031652) | 2.92733161 |
41 | positive regulation of interleukin-12 production (GO:0032735) | 2.92636134 |
42 | desmosome organization (GO:0002934) | 2.92411241 |
43 | cellular response to growth hormone stimulus (GO:0071378) | 2.90990566 |
44 | response to interleukin-15 (GO:0070672) | 2.90613884 |
45 | membrane raft organization (GO:0031579) | 2.87500630 |
46 | embryonic process involved in female pregnancy (GO:0060136) | 2.86243425 |
47 | positive regulation of extracellular matrix organization (GO:1903055) | 2.86018745 |
48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83862191 |
49 | regulation of integrin activation (GO:0033623) | 2.83344528 |
50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83250821 |
51 | negative regulation of cell killing (GO:0031342) | 2.83250821 |
52 | regulation of fever generation (GO:0031620) | 2.79846095 |
53 | regulation of histone H3-K27 methylation (GO:0061085) | 2.79400035 |
54 | negative regulation of lipid storage (GO:0010888) | 2.77892405 |
55 | myeloid dendritic cell activation (GO:0001773) | 2.75767949 |
56 | response to laminar fluid shear stress (GO:0034616) | 2.75043130 |
57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74485957 |
58 | regulation of chronic inflammatory response (GO:0002676) | 2.73631372 |
59 | positive regulation of humoral immune response (GO:0002922) | 2.73579788 |
60 | cellular response to interleukin-15 (GO:0071350) | 2.73085590 |
61 | response to peptidoglycan (GO:0032494) | 2.72988964 |
62 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.72460475 |
63 | regulation of T-helper cell differentiation (GO:0045622) | 2.72425274 |
64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.71031744 |
65 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.70861907 |
66 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70154921 |
67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69246767 |
68 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.68754052 |
69 | thymic T cell selection (GO:0045061) | 2.67673544 |
70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67646331 |
71 | positive regulation of activated T cell proliferation (GO:0042104) | 2.67416340 |
72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.66354308 |
73 | regulation of hypersensitivity (GO:0002883) | 2.65709284 |
74 | positive regulation of interleukin-17 production (GO:0032740) | 2.65317481 |
75 | regulation of T cell tolerance induction (GO:0002664) | 2.64632356 |
76 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.63961031 |
77 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.63733953 |
78 | T cell activation involved in immune response (GO:0002286) | 2.63207940 |
79 | regulation of water loss via skin (GO:0033561) | 2.63127710 |
80 | positive regulation of type 2 immune response (GO:0002830) | 2.60882957 |
81 | COPI coating of Golgi vesicle (GO:0048205) | 2.60441641 |
82 | Golgi transport vesicle coating (GO:0048200) | 2.60441641 |
83 | positive regulation of macrophage differentiation (GO:0045651) | 2.58448478 |
84 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58068746 |
85 | granulocyte activation (GO:0036230) | 2.57670474 |
86 | response to type I interferon (GO:0034340) | 2.56636475 |
87 | negative regulation of interleukin-2 production (GO:0032703) | 2.56479184 |
88 | monocyte chemotaxis (GO:0002548) | 2.55420308 |
89 | protein localization to endosome (GO:0036010) | 2.54999586 |
90 | positive regulation of interleukin-2 production (GO:0032743) | 2.54504368 |
91 | neutrophil activation involved in immune response (GO:0002283) | 2.54140321 |
92 | regulation of interleukin-12 production (GO:0032655) | 2.54012226 |
93 | positive regulation of defense response to virus by host (GO:0002230) | 2.53280762 |
94 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.53277654 |
95 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53096347 |
96 | regulation of T-helper 1 type immune response (GO:0002825) | 2.52997360 |
97 | cellular response to type I interferon (GO:0071357) | 2.52491412 |
98 | type I interferon signaling pathway (GO:0060337) | 2.52491412 |
99 | regulation of vitamin metabolic process (GO:0030656) | 2.52370215 |
100 | positive regulation of osteoclast differentiation (GO:0045672) | 2.52176216 |
101 | detection of bacterium (GO:0016045) | 2.51997029 |
102 | keratinization (GO:0031424) | 2.50353758 |
103 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.48952844 |
104 | pinocytosis (GO:0006907) | 2.48536837 |
105 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.48434534 |
106 | neutrophil activation (GO:0042119) | 2.48197610 |
107 | T-helper 1 type immune response (GO:0042088) | 2.47560158 |
108 | T cell selection (GO:0045058) | 2.47501042 |
109 | regulation of podosome assembly (GO:0071801) | 2.46876082 |
110 | detection of other organism (GO:0098543) | 2.46213568 |
111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46160981 |
112 | regulation of p38MAPK cascade (GO:1900744) | 2.45799249 |
113 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44494554 |
114 | positive regulation of isotype switching (GO:0045830) | 2.44479762 |
115 | response to protozoan (GO:0001562) | 2.44085222 |
116 | establishment of skin barrier (GO:0061436) | 2.42500955 |
117 | positive regulation of B cell mediated immunity (GO:0002714) | 2.42077407 |
118 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.42077407 |
119 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.40309613 |
120 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.40072992 |
121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.39736039 |
122 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.39374132 |
123 | regulation of heat generation (GO:0031650) | 2.39059372 |
124 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.38687124 |
125 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.37556716 |
126 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.37521594 |
127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.37175707 |
128 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.37114740 |
129 | establishment of endothelial barrier (GO:0061028) | 2.35109726 |
130 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35057006 |
131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.33144335 |
132 | positive regulation of astrocyte differentiation (GO:0048711) | 2.32578949 |
133 | uronic acid metabolic process (GO:0006063) | 2.32545843 |
134 | glucuronate metabolic process (GO:0019585) | 2.32545843 |
135 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.32148443 |
136 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.31211931 |
137 | mannose metabolic process (GO:0006013) | 2.31104108 |
138 | lymphocyte chemotaxis (GO:0048247) | 2.29861711 |
139 | cellular extravasation (GO:0045123) | 2.29825325 |
140 | cellular glucuronidation (GO:0052695) | 2.29074895 |
141 | regulation of immunoglobulin secretion (GO:0051023) | 2.28484579 |
142 | alpha-beta T cell activation (GO:0046631) | 2.27967534 |
143 | regulation of necroptotic process (GO:0060544) | 2.27890070 |
144 | T cell migration (GO:0072678) | 2.26506470 |
145 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.26362610 |
146 | regulation of interleukin-2 production (GO:0032663) | 2.26354339 |
147 | lymphocyte migration (GO:0072676) | 2.26345924 |
148 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.25732685 |
149 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.25726795 |
150 | regulation of defense response to virus by host (GO:0050691) | 2.25145543 |
151 | mammary gland epithelial cell proliferation (GO:0033598) | 2.22286336 |
152 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.20090609 |
153 | hemidesmosome assembly (GO:0031581) | 2.19834501 |
154 | defense response to protozoan (GO:0042832) | 2.17518430 |
155 | negative regulation of T cell mediated immunity (GO:0002710) | 2.17055164 |
156 | response to thyroid hormone (GO:0097066) | 2.15716135 |
157 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.15441424 |
158 | negative regulation of complement activation (GO:0045916) | 2.14040540 |
159 | stress fiber assembly (GO:0043149) | 2.13948483 |
160 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.13161727 |
161 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.11792984 |
162 | iron ion import (GO:0097286) | 2.11503940 |
163 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.11073602 |
164 | hypotonic response (GO:0006971) | 2.10739521 |
165 | detection of biotic stimulus (GO:0009595) | 2.09758747 |
166 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.09232167 |
167 | macrophage activation involved in immune response (GO:0002281) | 2.09106903 |
168 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.08917286 |
169 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.08895377 |
170 | negative regulation of humoral immune response (GO:0002921) | 2.08686437 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.08668213 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14170660 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87091537 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.75952528 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58739650 |
6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.43146823 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13438018 |
8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.97486286 |
9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79115911 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.76903436 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.67407532 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35202629 |
13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27263473 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26654716 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25919569 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23008201 |
17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19385642 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18755593 |
19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10581341 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10366445 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05749082 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05457437 |
23 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.04792720 |
24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99611221 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 1.99042368 |
26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82278322 |
27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82146882 |
28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81734646 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79541344 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72315696 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71321541 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70156800 |
33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68558199 |
34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67013436 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66403330 |
36 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.65339732 |
37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.63400790 |
38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.62368103 |
39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62126034 |
40 | * MAF_26560356_Chip-Seq_TH1_Human | 1.57586403 |
41 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55162778 |
42 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.50652101 |
43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49703958 |
44 | * MYB_26560356_Chip-Seq_TH2_Human | 1.49558728 |
45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48462092 |
46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43144314 |
47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42369131 |
48 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39102890 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38854577 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37721117 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.36153727 |
52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35912323 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34014461 |
54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32905995 |
55 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32891825 |
56 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31568862 |
57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28920899 |
58 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28622343 |
59 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26702767 |
60 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26199497 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26047033 |
62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25640354 |
63 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24881967 |
64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23875585 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20896505 |
66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18438409 |
67 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16235734 |
68 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15291240 |
69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15033281 |
70 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14885861 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.14438691 |
72 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14343127 |
73 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14024539 |
74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11757654 |
75 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.10422330 |
76 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10337897 |
77 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09808122 |
78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09808122 |
79 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07770314 |
80 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06913099 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06574483 |
82 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.05456901 |
83 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05351045 |
84 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05290030 |
85 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05290030 |
86 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.04927435 |
87 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04825591 |
88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04594161 |
89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04351851 |
90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04307125 |
91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03364763 |
92 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03156054 |
93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02822907 |
94 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02476155 |
95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02467714 |
96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02177158 |
97 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01313848 |
98 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97042887 |
99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95727133 |
100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94835318 |
101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93980376 |
102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93980376 |
103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93224186 |
104 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91050951 |
105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89591559 |
106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89324243 |
107 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88686839 |
108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87968176 |
109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87793631 |
110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87203552 |
111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87054339 |
112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86822045 |
113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85858898 |
114 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85713076 |
115 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84422148 |
116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83114302 |
117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82800201 |
118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82338045 |
119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81936619 |
120 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.81776480 |
121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81454818 |
122 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80670748 |
123 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80531859 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000685_abnormal_immune_system | 3.21081432 |
2 | MP0001835_abnormal_antigen_presentation | 3.08887306 |
3 | MP0003436_decreased_susceptibility_to | 3.07203845 |
4 | MP0003724_increased_susceptibility_to | 3.07155441 |
5 | MP0004510_myositis | 2.76504910 |
6 | MP0002138_abnormal_hepatobiliary_system | 2.73228584 |
7 | MP0009785_altered_susceptibility_to | 2.64969866 |
8 | MP0002254_reproductive_system_inflammat | 2.64364570 |
9 | MP0003303_peritoneal_inflammation | 2.59489731 |
10 | * MP0005387_immune_system_phenotype | 2.56884904 |
11 | * MP0001790_abnormal_immune_system | 2.56884904 |
12 | MP0005671_abnormal_response_to | 2.43854850 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.37538784 |
14 | * MP0005000_abnormal_immune_tolerance | 2.37192497 |
15 | MP0002405_respiratory_system_inflammati | 2.14123724 |
16 | * MP0001800_abnormal_humoral_immune | 2.11581291 |
17 | MP0001853_heart_inflammation | 2.09984504 |
18 | MP0002877_abnormal_melanocyte_morpholog | 2.08549676 |
19 | MP0002419_abnormal_innate_immunity | 2.07302773 |
20 | MP0004947_skin_inflammation | 2.05853902 |
21 | MP0006082_CNS_inflammation | 2.03901976 |
22 | * MP0002723_abnormal_immune_serum | 1.99325111 |
23 | MP0002796_impaired_skin_barrier | 1.98935036 |
24 | * MP0002452_abnormal_antigen_presenting | 1.96730720 |
25 | MP0005025_abnormal_response_to | 1.95519828 |
26 | MP0003300_gastrointestinal_ulcer | 1.94749230 |
27 | MP0005275_abnormal_skin_tensile | 1.88614768 |
28 | MP0010155_abnormal_intestine_physiology | 1.87983997 |
29 | MP0002166_altered_tumor_susceptibility | 1.86267453 |
30 | MP0005058_abnormal_lysosome_morphology | 1.84953400 |
31 | MP0003453_abnormal_keratinocyte_physiol | 1.81908728 |
32 | MP0005076_abnormal_cell_differentiation | 1.76030824 |
33 | MP0005451_abnormal_body_composition | 1.75516133 |
34 | MP0009278_abnormal_bone_marrow | 1.73387344 |
35 | MP0002006_tumorigenesis | 1.72809470 |
36 | * MP0001819_abnormal_immune_cell | 1.71913313 |
37 | MP0002009_preneoplasia | 1.71725446 |
38 | * MP0002420_abnormal_adaptive_immunity | 1.71380466 |
39 | MP0003763_abnormal_thymus_physiology | 1.69551629 |
40 | MP0001533_abnormal_skeleton_physiology | 1.66712615 |
41 | MP0009840_abnormal_foam_cell | 1.66322545 |
42 | MP0009764_decreased_sensitivity_to | 1.60075026 |
43 | MP0002933_joint_inflammation | 1.58948576 |
44 | MP0005360_urolithiasis | 1.56870564 |
45 | MP0008438_abnormal_cutaneous_collagen | 1.56487606 |
46 | MP0001845_abnormal_inflammatory_respons | 1.55935528 |
47 | MP0003448_altered_tumor_morphology | 1.55255390 |
48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47874655 |
49 | MP0003075_altered_response_to | 1.47595943 |
50 | MP0001873_stomach_inflammation | 1.46217837 |
51 | MP0005365_abnormal_bile_salt | 1.45981116 |
52 | MP0002998_abnormal_bone_remodeling | 1.43611751 |
53 | MP0003705_abnormal_hypodermis_morpholog | 1.41897437 |
54 | MP0003183_abnormal_peptide_metabolism | 1.39485830 |
55 | MP0002139_abnormal_hepatobiliary_system | 1.38592325 |
56 | MP0005085_abnormal_gallbladder_physiolo | 1.38093644 |
57 | MP0003566_abnormal_cell_adhesion | 1.37839810 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.37759728 |
59 | MP0001881_abnormal_mammary_gland | 1.35018973 |
60 | MP0005397_hematopoietic_system_phenotyp | 1.31670757 |
61 | MP0001545_abnormal_hematopoietic_system | 1.31670757 |
62 | * MP0000716_abnormal_immune_system | 1.26480756 |
63 | MP0003172_abnormal_lysosome_physiology | 1.26311840 |
64 | MP0000343_altered_response_to | 1.24688494 |
65 | MP0010329_abnormal_lipoprotein_level | 1.23935743 |
66 | MP0005464_abnormal_platelet_physiology | 1.20482061 |
67 | MP0008469_abnormal_protein_level | 1.19998774 |
68 | MP0004381_abnormal_hair_follicle | 1.17997943 |
69 | MP0003828_pulmonary_edema | 1.16978680 |
70 | * MP0002398_abnormal_bone_marrow | 1.16781183 |
71 | MP0001851_eye_inflammation | 1.16205131 |
72 | MP0000858_altered_metastatic_potential | 1.16183786 |
73 | MP0010678_abnormal_skin_adnexa | 1.15908821 |
74 | MP0000249_abnormal_blood_vessel | 1.15464682 |
75 | MP0003950_abnormal_plasma_membrane | 1.13839454 |
76 | MP0000609_abnormal_liver_physiology | 1.13154872 |
77 | MP0005310_abnormal_salivary_gland | 1.12491716 |
78 | MP0009333_abnormal_splenocyte_physiolog | 1.11650791 |
79 | MP0003091_abnormal_cell_migration | 1.10594097 |
80 | MP0003252_abnormal_bile_duct | 1.09949997 |
81 | MP0003191_abnormal_cellular_cholesterol | 1.09942064 |
82 | MP0004808_abnormal_hematopoietic_stem | 1.08311588 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 1.06755140 |
84 | MP0003866_abnormal_defecation | 1.06679426 |
85 | MP0000383_abnormal_hair_follicle | 1.06358209 |
86 | MP0004019_abnormal_vitamin_homeostasis | 1.06298503 |
87 | MP0005023_abnormal_wound_healing | 1.05153334 |
88 | MP0005501_abnormal_skin_physiology | 1.05033454 |
89 | MP0005257_abnormal_intraocular_pressure | 1.04908302 |
90 | MP0005166_decreased_susceptibility_to | 1.03319303 |
91 | MP0005670_abnormal_white_adipose | 1.01617745 |
92 | MP0005375_adipose_tissue_phenotype | 1.01072709 |
93 | MP0001348_abnormal_lacrimal_gland | 1.01070254 |
94 | MP0005164_abnormal_response_to | 1.00288682 |
95 | MP0005390_skeleton_phenotype | 0.99066584 |
96 | MP0010368_abnormal_lymphatic_system | 0.97648094 |
97 | * MP0002722_abnormal_immune_system | 0.97408974 |
98 | * MP0000689_abnormal_spleen_morphology | 0.97194075 |
99 | MP0005409_darkened_coat_color | 0.97132962 |
100 | MP0003045_fibrosis | 0.96574658 |
101 | MP0005666_abnormal_adipose_tissue | 0.96078705 |
102 | MP0001958_emphysema | 0.95734077 |
103 | MP0004883_abnormal_blood_vessel | 0.94874552 |
104 | MP0000003_abnormal_adipose_tissue | 0.93585231 |
105 | * MP0002429_abnormal_blood_cell | 0.91812190 |
106 | MP0009931_abnormal_skin_appearance | 0.91318047 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.90306115 |
108 | MP0001346_abnormal_lacrimal_gland | 0.88908923 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.87587833 |
110 | MP0000604_amyloidosis | 0.86570891 |
111 | MP0002060_abnormal_skin_morphology | 0.86517268 |
112 | MP0009763_increased_sensitivity_to | 0.86421700 |
113 | MP0004782_abnormal_surfactant_physiolog | 0.85741338 |
114 | MP0001879_abnormal_lymphatic_vessel | 0.84482303 |
115 | MP0000627_abnormal_mammary_gland | 0.83831724 |
116 | MP0009115_abnormal_fat_cell | 0.82714682 |
117 | MP0000678_abnormal_parathyroid_gland | 0.82487238 |
118 | MP0010234_abnormal_vibrissa_follicle | 0.81463963 |
119 | MP0008961_abnormal_basal_metabolism | 0.80906285 |
120 | MP0008260_abnormal_autophagy | 0.79069435 |
121 | MP0003279_aneurysm | 0.78432807 |
122 | MP0001216_abnormal_epidermal_layer | 0.78207484 |
123 | MP0005165_increased_susceptibility_to | 0.77678251 |
124 | MP0002136_abnormal_kidney_physiology | 0.76288527 |
125 | MP0004264_abnormal_extraembryonic_tissu | 0.76019545 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Optic neuritis (HP:0100653) | 5.55368786 |
2 | Retrobulbar optic neuritis (HP:0100654) | 5.55368786 |
3 | Orchitis (HP:0100796) | 5.39940878 |
4 | Myositis (HP:0100614) | 4.91425269 |
5 | Eczematoid dermatitis (HP:0000976) | 4.65957419 |
6 | Myocardial infarction (HP:0001658) | 4.20365418 |
7 | Keratoconjunctivitis sicca (HP:0001097) | 3.90134024 |
8 | Arterial thrombosis (HP:0004420) | 3.67874975 |
9 | Keratoconjunctivitis (HP:0001096) | 3.55169172 |
10 | Increased IgM level (HP:0003496) | 3.49492741 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.41949685 |
12 | Pulmonary infiltrates (HP:0002113) | 3.36067246 |
13 | Persistence of primary teeth (HP:0006335) | 3.27280204 |
14 | Recurrent fungal infections (HP:0002841) | 3.26171948 |
15 | Gastrointestinal infarctions (HP:0005244) | 3.22213832 |
16 | Esophageal varix (HP:0002040) | 3.12391407 |
17 | Increased density of long bones (HP:0006392) | 3.09870809 |
18 | Alopecia of scalp (HP:0002293) | 3.09859946 |
19 | Abnormality of nail color (HP:0100643) | 3.07677333 |
20 | Mediastinal lymphadenopathy (HP:0100721) | 3.06513863 |
21 | Pustule (HP:0200039) | 3.05299990 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.00850306 |
23 | Vasculitis (HP:0002633) | 2.95815166 |
24 | Anorexia (HP:0002039) | 2.94191717 |
25 | Polycythemia (HP:0001901) | 2.92357313 |
26 | Autoimmune thrombocytopenia (HP:0001973) | 2.88732447 |
27 | Recurrent bacterial skin infections (HP:0005406) | 2.88662023 |
28 | Interstitial pulmonary disease (HP:0006530) | 2.88407160 |
29 | Hemoptysis (HP:0002105) | 2.83204113 |
30 | Joint swelling (HP:0001386) | 2.78624318 |
31 | Recurrent abscess formation (HP:0002722) | 2.78450797 |
32 | Pulmonary embolism (HP:0002204) | 2.75790986 |
33 | Stomatitis (HP:0010280) | 2.70485152 |
34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.66506157 |
35 | Right ventricular cardiomyopathy (HP:0011663) | 2.63533652 |
36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62038114 |
37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62038114 |
38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62038114 |
39 | Gingival bleeding (HP:0000225) | 2.61539422 |
40 | Abnormality of T cell number (HP:0011839) | 2.56116293 |
41 | Deep venous thrombosis (HP:0002625) | 2.53367135 |
42 | Glomerulonephritis (HP:0000099) | 2.52227301 |
43 | IgA deficiency (HP:0002720) | 2.48778099 |
44 | Abnormality of the nasal septum (HP:0000419) | 2.46921219 |
45 | Dysostosis multiplex (HP:0000943) | 2.46911180 |
46 | Gangrene (HP:0100758) | 2.46315481 |
47 | Abnormality of macrophages (HP:0004311) | 2.45982306 |
48 | Thrombophlebitis (HP:0004418) | 2.41062538 |
49 | Abnormality of proline metabolism (HP:0010907) | 2.39919294 |
50 | Hydroxyprolinuria (HP:0003080) | 2.39919294 |
51 | Xanthomatosis (HP:0000991) | 2.33715989 |
52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30651275 |
53 | Abnormality of the pericardium (HP:0001697) | 2.30173029 |
54 | Nasal polyposis (HP:0100582) | 2.20277693 |
55 | Onycholysis (HP:0001806) | 2.20092104 |
56 | Joint hemorrhage (HP:0005261) | 2.19867055 |
57 | Fatigue (HP:0012378) | 2.18143723 |
58 | T lymphocytopenia (HP:0005403) | 2.17503923 |
59 | Recurrent skin infections (HP:0001581) | 2.16909237 |
60 | Systemic lupus erythematosus (HP:0002725) | 2.16637948 |
61 | Peritonitis (HP:0002586) | 2.15112757 |
62 | Abnormal gallbladder physiology (HP:0012438) | 2.14004051 |
63 | Cholecystitis (HP:0001082) | 2.14004051 |
64 | Abnormality of the nasal mucosa (HP:0000433) | 2.13806841 |
65 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12696290 |
66 | Gingivitis (HP:0000230) | 2.11306630 |
67 | Tetraparesis (HP:0002273) | 2.11004748 |
68 | Broad face (HP:0000283) | 2.09574283 |
69 | Premature loss of primary teeth (HP:0006323) | 2.09110786 |
70 | Distal lower limb amyotrophy (HP:0008944) | 2.08697038 |
71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07398958 |
72 | Cerebral aneurysm (HP:0004944) | 2.06293399 |
73 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.05531690 |
74 | Increased connective tissue (HP:0009025) | 2.05046391 |
75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04211613 |
76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04211613 |
77 | Autoimmune hemolytic anemia (HP:0001890) | 2.03946236 |
78 | Osteolytic defects of the hand bones (HP:0009699) | 2.03455218 |
79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03455218 |
80 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02790324 |
81 | Neurofibrillary tangles (HP:0002185) | 2.02090041 |
82 | Abnormal blistering of the skin (HP:0008066) | 2.01966601 |
83 | Protrusio acetabuli (HP:0003179) | 2.01412652 |
84 | Hypergammaglobulinemia (HP:0010702) | 2.00768912 |
85 | Abnormality of T cells (HP:0002843) | 1.99596847 |
86 | Ankyloglossia (HP:0010296) | 1.98814739 |
87 | Abnormality of oral frenula (HP:0000190) | 1.98809232 |
88 | Milia (HP:0001056) | 1.98217241 |
89 | Mitral stenosis (HP:0001718) | 1.98187531 |
90 | Obstructive sleep apnea (HP:0002870) | 1.97953014 |
91 | Cheilitis (HP:0100825) | 1.97108205 |
92 | Periodontitis (HP:0000704) | 1.96563361 |
93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96449542 |
94 | Mucopolysacchariduria (HP:0008155) | 1.96449542 |
95 | Encephalitis (HP:0002383) | 1.95556167 |
96 | Menorrhagia (HP:0000132) | 1.94781234 |
97 | Plantar hyperkeratosis (HP:0007556) | 1.94583645 |
98 | Nail dystrophy (HP:0008404) | 1.92701961 |
99 | Gastrointestinal stroma tumor (HP:0100723) | 1.92683614 |
100 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91995594 |
101 | Vertebral compression fractures (HP:0002953) | 1.91359108 |
102 | Increased cerebral lipofuscin (HP:0011813) | 1.91222690 |
103 | Increased mean platelet volume (HP:0011877) | 1.91029357 |
104 | Axonal loss (HP:0003447) | 1.89817395 |
105 | Arthralgia (HP:0002829) | 1.89661608 |
106 | IgM deficiency (HP:0002850) | 1.89640661 |
107 | Asymmetric septal hypertrophy (HP:0001670) | 1.89618109 |
108 | Spondylolisthesis (HP:0003302) | 1.89373579 |
109 | Colitis (HP:0002583) | 1.89343576 |
110 | Abnormal platelet volume (HP:0011876) | 1.89196563 |
111 | Meningitis (HP:0001287) | 1.88714591 |
112 | Leukocytosis (HP:0001974) | 1.88392351 |
113 | Loss of speech (HP:0002371) | 1.86041297 |
114 | Recurrent viral infections (HP:0004429) | 1.85781291 |
115 | Vascular calcification (HP:0004934) | 1.85716197 |
116 | Intrahepatic cholestasis (HP:0001406) | 1.85249733 |
117 | Inflammation of the large intestine (HP:0002037) | 1.85004994 |
118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84848299 |
119 | Spontaneous hematomas (HP:0007420) | 1.84134377 |
120 | Thick nail (HP:0001805) | 1.83752531 |
121 | Increased IgE level (HP:0003212) | 1.83669886 |
122 | Distal lower limb muscle weakness (HP:0009053) | 1.82540716 |
123 | Dilatation of the ascending aorta (HP:0005111) | 1.82424336 |
124 | Lip pit (HP:0100267) | 1.81791045 |
125 | Nephritis (HP:0000123) | 1.81722671 |
126 | Prostate neoplasm (HP:0100787) | 1.81227108 |
127 | Abnormality of T cell physiology (HP:0011840) | 1.81051879 |
128 | Emphysema (HP:0002097) | 1.80836574 |
129 | Exercise-induced myalgia (HP:0003738) | 1.80829728 |
130 | Erythema (HP:0010783) | 1.80720034 |
131 | Hemorrhage of the eye (HP:0011885) | 1.79569951 |
132 | Chronic diarrhea (HP:0002028) | 1.79367690 |
133 | Palmoplantar hyperkeratosis (HP:0000972) | 1.78194047 |
134 | Cardiovascular calcification (HP:0011915) | 1.77928285 |
135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77726939 |
136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77726939 |
137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77726939 |
138 | Bone pain (HP:0002653) | 1.77040343 |
139 | Glomerulopathy (HP:0100820) | 1.76375916 |
140 | Complement deficiency (HP:0004431) | 1.76000532 |
141 | Atrophic scars (HP:0001075) | 1.75700347 |
142 | Arterial tortuosity (HP:0005116) | 1.74617968 |
143 | Abnormality of complement system (HP:0005339) | 1.74252911 |
144 | Chronic otitis media (HP:0000389) | 1.73496698 |
145 | Flat acetabular roof (HP:0003180) | 1.69908562 |
146 | Advanced eruption of teeth (HP:0006288) | 1.67057401 |
147 | Malnutrition (HP:0004395) | 1.66616661 |
148 | Aortic dissection (HP:0002647) | 1.65969750 |
149 | Aneurysm (HP:0002617) | 1.65938687 |
150 | Increased serum ferritin (HP:0003281) | 1.65042409 |
151 | Recurrent bronchitis (HP:0002837) | 1.64848754 |
152 | Amyloidosis (HP:0011034) | 1.64532748 |
153 | Restrictive lung disease (HP:0002091) | 1.64010195 |
154 | Abnormality of the fingertips (HP:0001211) | 1.61631903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.41740419 |
2 | TXK | 3.61040164 |
3 | PRPF4B | 3.37092533 |
4 | MAP4K1 | 2.68607139 |
5 | MAPK15 | 2.65984137 |
6 | IRAK3 | 2.65905394 |
7 | TBK1 | 2.58108438 |
8 | IKBKB | 2.50169072 |
9 | JAK3 | 2.43130896 |
10 | TAOK3 | 2.42704220 |
11 | JAK1 | 2.40400973 |
12 | EPHB1 | 2.29526878 |
13 | CHUK | 2.15547265 |
14 | TYK2 | 2.12688398 |
15 | EPHA3 | 2.03405564 |
16 | BMX | 1.97438620 |
17 | IKBKE | 1.97125136 |
18 | FGFR4 | 1.95161113 |
19 | PIM2 | 1.94544871 |
20 | RIPK1 | 1.79657920 |
21 | PIM1 | 1.63860487 |
22 | FGFR3 | 1.53983260 |
23 | CSK | 1.53067182 |
24 | ITK | 1.46474594 |
25 | STK10 | 1.45473942 |
26 | EEF2K | 1.45172265 |
27 | CDC42BPA | 1.44164283 |
28 | SIK1 | 1.38043843 |
29 | MAP3K3 | 1.30244911 |
30 | MST4 | 1.29426423 |
31 | MAP3K11 | 1.26074033 |
32 | ICK | 1.25482101 |
33 | MAP3K13 | 1.20665612 |
34 | RIPK4 | 1.19136544 |
35 | CDK6 | 1.17827190 |
36 | JAK2 | 1.16593633 |
37 | TRIB3 | 1.16508927 |
38 | ERN1 | 1.15562957 |
39 | ZAP70 | 1.12930876 |
40 | MAPKAPK3 | 1.11322689 |
41 | NEK9 | 1.04905923 |
42 | GSK3A | 1.03194849 |
43 | PTK6 | 1.02021098 |
44 | MAP2K6 | 1.01565629 |
45 | SIK3 | 1.01083585 |
46 | TGFBR2 | 1.00648567 |
47 | NLK | 0.98729265 |
48 | TRPM7 | 0.98161811 |
49 | HCK | 0.97900387 |
50 | STK24 | 0.95693033 |
51 | MOS | 0.95602924 |
52 | KSR2 | 0.92534308 |
53 | TEC | 0.91977146 |
54 | EPHA2 | 0.91174597 |
55 | MST1R | 0.89213492 |
56 | BLK | 0.87421355 |
57 | LATS2 | 0.86169811 |
58 | MAP2K3 | 0.85090924 |
59 | DMPK | 0.84761242 |
60 | MATK | 0.82783877 |
61 | MTOR | 0.80968017 |
62 | LCK | 0.80846998 |
63 | MAPK11 | 0.80196924 |
64 | FGR | 0.78206362 |
65 | BMPR2 | 0.77827951 |
66 | IRAK4 | 0.75983824 |
67 | MAP3K9 | 0.75431715 |
68 | NME2 | 0.72296852 |
69 | MAP2K2 | 0.72271093 |
70 | GRK6 | 0.72016482 |
71 | PDGFRB | 0.70375863 |
72 | BTK | 0.70100468 |
73 | MARK2 | 0.69744263 |
74 | RPS6KA4 | 0.69664117 |
75 | MAPKAPK2 | 0.69302599 |
76 | PDPK1 | 0.69129771 |
77 | SMG1 | 0.67850793 |
78 | SYK | 0.67638879 |
79 | MARK3 | 0.66678974 |
80 | PDK1 | 0.66136010 |
81 | PDK2 | 0.66025509 |
82 | PRKCQ | 0.64715352 |
83 | RET | 0.64466492 |
84 | DDR2 | 0.63466766 |
85 | TAOK2 | 0.62633506 |
86 | LRRK2 | 0.59435035 |
87 | PIK3CG | 0.58198259 |
88 | PKN2 | 0.57871881 |
89 | TTN | 0.57515093 |
90 | WNK1 | 0.56884488 |
91 | MET | 0.56202360 |
92 | RPS6KA1 | 0.55856221 |
93 | MAP3K7 | 0.55374971 |
94 | NEK6 | 0.54199221 |
95 | ARAF | 0.54174352 |
96 | KDR | 0.53736764 |
97 | MAP3K6 | 0.53516303 |
98 | IRAK1 | 0.52921290 |
99 | ABL1 | 0.52798013 |
100 | STK3 | 0.51160431 |
101 | MAP3K1 | 0.50128890 |
102 | KIT | 0.48956412 |
103 | IRAK2 | 0.47641605 |
104 | SIK2 | 0.45452225 |
105 | PTK2 | 0.45278629 |
106 | EGFR | 0.43931804 |
107 | DYRK1B | 0.43434088 |
108 | CDK12 | 0.43396930 |
109 | TAOK1 | 0.42933163 |
110 | CSF1R | 0.42855831 |
111 | HIPK2 | 0.42340974 |
112 | MAP3K2 | 0.41751427 |
113 | NTRK1 | 0.41426472 |
114 | MAPK4 | 0.40813776 |
115 | PAK4 | 0.40615050 |
116 | PRKD2 | 0.40129710 |
117 | LYN | 0.40037687 |
118 | MAP3K5 | 0.38542887 |
119 | RPS6KA6 | 0.37964136 |
120 | SGK3 | 0.37869419 |
121 | INSR | 0.37224668 |
122 | FES | 0.34618036 |
123 | PTK2B | 0.34131869 |
124 | PDGFRA | 0.32919964 |
125 | IGF1R | 0.32681742 |
126 | NUAK1 | 0.32407360 |
127 | MAPK7 | 0.32173885 |
128 | FER | 0.31153124 |
129 | MAPK3 | 0.30774791 |
130 | MAPK12 | 0.29312856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.03278981 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.76232668 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.43376427 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27268494 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22999373 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22995487 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21559665 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03956139 |
9 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01021824 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.93379285 |
11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91850413 |
12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85215136 |
13 | Measles_Homo sapiens_hsa05162 | 1.75479937 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.63004737 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56466326 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55765093 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55745875 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55034525 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54950682 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54281127 |
21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50410907 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49651400 |
23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49403214 |
24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45090096 |
25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42931520 |
26 | Malaria_Homo sapiens_hsa05144 | 1.36461120 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35733004 |
28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35176152 |
29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34884948 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31970684 |
31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28876049 |
32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27383461 |
33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24955083 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23543169 |
35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22400749 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22009462 |
37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18431524 |
38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17484990 |
39 | Influenza A_Homo sapiens_hsa05164 | 1.16147773 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.15951536 |
41 | Apoptosis_Homo sapiens_hsa04210 | 1.13298425 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08723464 |
43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06803614 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06028470 |
45 | Tuberculosis_Homo sapiens_hsa05152 | 1.04565197 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00713191 |
47 | Shigellosis_Homo sapiens_hsa05131 | 0.97976260 |
48 | Salmonella infection_Homo sapiens_hsa05132 | 0.96583071 |
49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95954818 |
50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95246364 |
51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95180604 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94953167 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94896606 |
54 | Bladder cancer_Homo sapiens_hsa05219 | 0.93526969 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.89489195 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87488671 |
57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87026741 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86316111 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85795531 |
60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85419136 |
61 | Amoebiasis_Homo sapiens_hsa05146 | 0.81329223 |
62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80223745 |
63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78445535 |
64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77999576 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77738142 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77643895 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75898083 |
68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75586155 |
69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74318139 |
70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73461649 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73242517 |
72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73208822 |
73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71427927 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.71280969 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.71237483 |
76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70085351 |
77 | Asthma_Homo sapiens_hsa05310 | 0.69940922 |
78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68835021 |
79 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.68346329 |
80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67636107 |
81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67280631 |
82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66155314 |
83 | Adherens junction_Homo sapiens_hsa04520 | 0.62778865 |
84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61537471 |
85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61329429 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.60964303 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60646725 |
88 | Prostate cancer_Homo sapiens_hsa05215 | 0.60534331 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59563090 |
90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59406571 |
91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59221142 |
92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58566636 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58558491 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56467485 |
95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56251722 |
96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55432985 |
97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55285174 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54838887 |
99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54006072 |
100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53691436 |
101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53337577 |
102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53336752 |
103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53020442 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.52516407 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52294621 |
106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52148025 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51756249 |
108 | Focal adhesion_Homo sapiens_hsa04510 | 0.51254379 |
109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49354093 |
110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48430429 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47118205 |
112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46655678 |
113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46347111 |
114 | Platelet activation_Homo sapiens_hsa04611 | 0.46227158 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46127546 |
116 | Bile secretion_Homo sapiens_hsa04976 | 0.45953651 |
117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45303057 |
118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41983189 |
119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41960544 |
120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41717821 |
121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41106549 |
122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39722793 |
123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38320603 |
124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37761584 |
125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36334169 |
126 | Phagosome_Homo sapiens_hsa04145 | 0.36009113 |
127 | Lysosome_Homo sapiens_hsa04142 | 0.34392674 |
128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32478739 |